1. Home
  2. CTMX vs INTT Comparison

CTMX vs INTT Comparison

Compare CTMX & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • INTT
  • Stock Information
  • Founded
  • CTMX 2008
  • INTT 1981
  • Country
  • CTMX United States
  • INTT United States
  • Employees
  • CTMX N/A
  • INTT N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • INTT Semiconductors
  • Sector
  • CTMX Health Care
  • INTT Technology
  • Exchange
  • CTMX Nasdaq
  • INTT Nasdaq
  • Market Cap
  • CTMX 85.3M
  • INTT 91.4M
  • IPO Year
  • CTMX 2015
  • INTT 1997
  • Fundamental
  • Price
  • CTMX $0.87
  • INTT $8.86
  • Analyst Decision
  • CTMX Buy
  • INTT Strong Buy
  • Analyst Count
  • CTMX 6
  • INTT 2
  • Target Price
  • CTMX $5.77
  • INTT $16.00
  • AVG Volume (30 Days)
  • CTMX 943.6K
  • INTT 28.6K
  • Earning Date
  • CTMX 03-10-2025
  • INTT 03-26-2025
  • Dividend Yield
  • CTMX N/A
  • INTT N/A
  • EPS Growth
  • CTMX N/A
  • INTT N/A
  • EPS
  • CTMX 0.16
  • INTT 0.22
  • Revenue
  • CTMX $126,617,000.00
  • INTT $121,971,000.00
  • Revenue This Year
  • CTMX $22.55
  • INTT $7.31
  • Revenue Next Year
  • CTMX N/A
  • INTT $5.77
  • P/E Ratio
  • CTMX $5.39
  • INTT $39.92
  • Revenue Growth
  • CTMX 33.66
  • INTT N/A
  • 52 Week Low
  • CTMX $0.79
  • INTT $6.28
  • 52 Week High
  • CTMX $5.85
  • INTT $14.35
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 45.10
  • INTT 51.29
  • Support Level
  • CTMX $0.82
  • INTT $8.70
  • Resistance Level
  • CTMX $0.92
  • INTT $9.30
  • Average True Range (ATR)
  • CTMX 0.06
  • INTT 0.41
  • MACD
  • CTMX 0.01
  • INTT -0.03
  • Stochastic Oscillator
  • CTMX 33.33
  • INTT 42.20

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). They operate their business worldwide and sells its products both domestically and internationally.

Share on Social Networks: